Liaoning Kelong Fine Chemical,Inc.: Announcement of Resolutions of the 12th Meeting of the Fifth Board of Supervisors
Liaoning Kelong Fine Chemical,Inc.: Independent Directors' Special Meeting Opinions on Granting Reserved Part II Restricted Shares to Incentive Recipients
Liaoning Kelong Fine Chemical,Inc.: Announcement of Resolutions of the 16th Meeting of the Fifth Board of Directors
Köln Shares: Report on the Work of the Board of Directors 2023
Colon Shares: Announcement of Board Resolutions
Cologne Co., Ltd.: Audit opinion of the Supervisory Board on the internal control self-evaluation report
Cologne Co., Ltd.: Board and Audit Committee's Opinions on Renewal of the Accounting Firm, Accounting for 2023 Credit Impairment Losses and Asset Impairment Losses, Accruing Impairment Losses on Long-term Equity Investments of Subsidiaries, and Internal Control Evaluation Reports
Colon Co., Ltd.: Announcement of 2023 related transactions and 2024 related transaction plans
Cologne Co., Ltd.: Independent Director's 2023 Debriefing Report - Liu Dongxue
Colon Shares: Announcement on changes in accounting policies
Colon Shares: Internal Control Verification Report
Köln Shares: 2023 Annual Audit Report
Cologne shares: independent directors' self-inspection report on independence in 2023
Colon Co., Ltd.: Announcement of Supervisory Board Resolutions
Colon Shares: Report on the Work of the Supervisory Committee for the Year 2023
Colon Co., Ltd.: Announcement on holding the 2023 annual results briefing
Colon Shares: Announcement on Renewal of the Accounting Firm
Cologne Co., Ltd.: Independent Director's 2023 Debriefing Report - Hou Qiaoming
Colon shares: asset evaluation report on 100% equity recoverable amount of Sichuan Hengze Building Materials Co., Ltd. involved in the proposed equity impairment test of Liaoning Kelong Fine Chemical Co., Ltd.
Colon Co., Ltd.: Independent Director's 2023 Debriefing Report - Gao Yiyun
No Data